The immune response to T helper (Th) cell determinants of a variety of anti
gens is often poor and limits severely the potential efficacy of current th
erapeutic measures through vaccination. Here, we report: that an immunologi
cally silent tumor determinant can be rendered immunogenic if linked with a
dominant determinant of a parasite antigen, suggesting the existence of fu
nctional Th-Th cooperation in vivo. This phenomenon could be mimicked in pa
rt by signaling either through CD40 to the antigen-presenting cells or thro
ugh OX40 to the tumor-determinant reactive T cells, with maximal effects ob
tained by combined anti-CD40 and anti-OX40 treatment in vivo. The data sugg
est that CD4 T cells reactive with a dominant determinant provide help to o
ther CD4 T cells through up-regulating the costimulatory ability of antigen
-presenting cells, in much the same way as help for CD8 cells. CD4 help for
CD4 T cells represents a new immunological principle and offers new practi
cal solutions for vaccine therapy against cancer and other diseases in whic
h antigenic help is limiting.